Evidence map›Paper›PMID 40981078›Full record

ArticleAdvances in respiratory medicine2025

FeNO 350 mL/s: Unlocking the Small Airways to Achieve Clinical Remission in Severe Asthma-A Pilot Study.

Vitaliano Nicola Quaranta, Andrea Portacci, Leonardo Maselli, Marta Tornesello, Maria Granito, Gennaro Rociola, Silvano Dragonieri, Giovanna Elisiana Carpagnano

Abstract read
In one paragraph

Article in Advances in respiratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Observational
  5. From FEVJournal of asthma and allergy · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vitaliano Nicola QuarantaInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.ORCID 0000-0001-9920-780X
Andrea PortacciInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.ORCID 0000-0002-6127-2486
Leonardo MaselliInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.
Marta TorneselloInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.
Maria GranitoInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.
Gennaro RociolaInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.
Silvano DragonieriInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.ORCID 0000-0003-1563-6864
Giovanna Elisiana CarpagnanoInstitute of Respiratory Disease, University of Bari, 70124 Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Asthmatic AgentsAsthmaFractional Exhaled Nitric Oxide TestingNitric OxideAdultAntibodies, Monoclonal, HumanizedBiomarkersFemaleHumansMaleMiddle AgedOmalizumabPilot ProjectsRemission InductionSeverity of Illness IndexAnti-Asthmatic AgentsAntibodies, Monoclonal, HumanizedBiomarkersNitric OxideOmalizumabclinical remissionFeNO 350 mL/ssevere asthmasmall airways disease

Identifiers

PMID40981078
PMCPMC12452774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.